siRNA, Anti-Human ACTG2, LNA(CAT#: SIRGT04046WQ-LNA)

The product SIRGT04046WQ-LNA is a type of small interfering RNA (siRNA) that targets ACTG2 gene and regulates the expression of gene. The siRNA interferes with the expression of ACTG2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001199893.1; NM_001615.3
Alternative Names ACT; ACTA3; ACTE; ACTL3; ACTSG; VSCM
Related Diseases Visceral Myopathy, Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome
Purification HPLC
Target Gene
Gene ID 72
Uniprot ID P63267

Related Products